Back to Search Start Over

118O Blood tumor mutational burden as a predictor of clinical benefit in non-small cell lung cancer patients treated with docetaxel: Secondary analysis of the OAK and POPLAR randomized clinical trials.

Authors :
Nie, W
Qian, J
Han, B-H
Source :
Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
Publication Year :
2019

Details

Language :
English
ISSN :
09237534
Volume :
30
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
136076490
Full Text :
https://doi.org/10.1093/annonc/mdz063.016